Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
NOTV Inotiv Inc
- Stocks
- Healthcare
- NASDAQ: NOTV
Price (delayed)
$2.26
Market cap
$77.64M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$3.19
Enterprise value
$507.09M
Bioanalytical Systems, Inc., operating as Inotiv, is a pharmaceutical development company providing contract research services and monitoring instruments to emerging pharmaceutical companies and the world's leading drug development companies and
Highlights
NOTV's gross profit is down by 37% YoY but it is up by 2.3% QoQ
Inotiv's EPS has increased by 31% from the previous quarter but it has decreased by 15% YoY
NOTV's gross margin is down by 28% year-on-year
The equity has declined by 24% year-on-year and by 7% since the previous quarter
Key stats
What are the main financial stats of NOTV
Market
Valuations
Earnings
Shares outstanding
34.35M
Market cap
$77.64M
Enterprise value
$507.09M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.49
Price to sales (P/S)
0.16
EV/EBIT
N/A
EV/EBITDA
89.7
EV/Sales
1.06
Revenue
$480.4M
Gross profit
$105.05M
Operating income
-$52.36M
Net income
-$87.47M
EBIT
-$51.06M
EBITDA
$5.65M
Free cash flow
-$52.6M
Per share
Balance sheet
Liquidity
EPS
-$3.19
EPS diluted
-$3.19
Free cash flow per share
-$1.55
Book value per share
$4.66
Revenue per share
$14.13
TBVPS
$12.21
Total assets
$765.97M
Total liabilities
$608.27M
Debt
$448.75M
Equity
$157.69M
Working capital
$58.25M
Debt to equity
2.85
Current ratio
1.5
Quick ratio
0.78
Net debt/EBITDA
75.97
Margins
Efficiency
Dividend
EBITDA margin
1.2%
Gross margin
21.9%
Net margin
-18.2%
Operating margin
-10.9%
Return on assets
-11.3%
Return on equity
-51.4%
Return on invested capital
-8.2%
Return on capital employed
-7.8%
Return on sales
-10.6%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
NOTV stock price
How has the Inotiv stock price performed over time
Intraday
11.33%
1 week
15.31%
1 month
36.97%
1 year
5.61%
YTD
-45.41%
QTD
2.26%
Financial performance
How have Inotiv's revenue and profit performed over time
Revenue
$480.4M
Gross profit
$105.05M
Operating income
-$52.36M
Net income
-$87.47M
Gross margin
21.9%
Net margin
-18.2%
The operating margin has decreased by 45% YoY but it has increased by 44% from the previous quarter
The operating income is up by 43% since the previous quarter but it has declined by 27% year-on-year
The net margin has contracted by 41% YoY but it has grown by 28% from the previous quarter
NOTV's gross profit is down by 37% YoY but it is up by 2.3% QoQ
Price vs fundamentals
How does NOTV's price correlate with its fundamentals
Growth
What is Inotiv's growth rate over time
Valuation
What is Inotiv stock price valuation
P/E
N/A
P/B
0.49
P/S
0.16
EV/EBIT
N/A
EV/EBITDA
89.7
EV/Sales
1.06
Inotiv's EPS has increased by 31% from the previous quarter but it has decreased by 15% YoY
The P/B is 88% lower than the 5-year quarterly average of 4.0 but 23% higher than the last 4 quarters average of 0.4
The equity has declined by 24% year-on-year and by 7% since the previous quarter
The price to sales (P/S) is 89% less than the 5-year quarterly average of 1.4 but 60% more than the last 4 quarters average of 0.1
Inotiv's revenue has decreased by 13% YoY
Efficiency
How efficient is Inotiv business performance
Inotiv's return on equity has shrunk by 82% YoY but it has increased by 22% QoQ
Inotiv's ROS has plunged by 56% YoY but it has increased by 45% from the previous quarter
The ROIC has soared by 53% QoQ but it is down by 37% YoY
The ROA fell by 33% YoY but it rose by 27% QoQ
Dividends
What is NOTV's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for NOTV.
Financial health
How did Inotiv financials performed over time
The total assets is 26% greater than the total liabilities
NOTV's quick ratio is down by 21% since the previous quarter
The total assets has declined by 6% year-on-year
The debt is 185% more than the equity
The company's debt to equity rose by 38% YoY and by 8% QoQ
The equity has declined by 24% year-on-year and by 7% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.